Regardless of its outcome, this class action will dramatically change pharmacy benefit management and the standard of care to which management will be held on benefit design.
Far too many pharmacy benefit managers (PBMs) thrive on opacity in their business operations, but sometimes public litigation shines the light of day on secretive practices.
Plan sponsors should consult with industry experts who have an in-depth knowledge of the PBM industry and who understand PBMs' lingo to uncover self-serving rebate arrangement.
DebugScreen: mobile
{
"author": {
"name": "Jonathan E Levitt",
"webUrl": "/author/profile/jonathan-e-levitt/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 5,
"social": [],
"articles": [
{
"uri": "/2024/03/12/pharmacy-benefit-design-johnson-johnson-lawsuit-ushers-in-new-duty-of-prudence-standard/",
"title": "Pharmacy benefit design: Johnson & Johnson lawsuit ushers in new 'duty of prudence' standard",
"byline": "Jonathan E. Levitt, Esq. and Dae Y. Lee, Pharm.D., Esq., CPBS",
"kicker": "Expert Opinion",
"prettyDate": "March 12, 2024",
"timeToRead": "9 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2024/03/Johnson-and-Johnson-PBM-Lawsuit-Animated-620x372-1.gif",
"width": "620",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/jonathan-e-levitt-esq/",
"name": "Jonathan E. Levitt, Esq."
},
{
"webUrl": "/author/profile/dae-y-lee-pharmd-esq-cpbs/",
"name": "Dae Y. Lee, Pharm.D., Esq., CPBS"
}
],
"kickerNode": [
{
"uri": "/expert-opinion/",
"sectionName": "Expert Opinion"
}
],
"summary": "Regardless of its outcome, this class action will dramatically change pharmacy benefit management and the standard of care to which management will be held on benefit design.",
"body": null
},
{
"uri": "/2022/06/15/pbms-could-be-driving-up-plan-sponsors-drug-costs/",
"title": "PBMs could be driving up plan sponsors' drug costs",
"byline": "Jonathan E. Levitt, Esq., Dae Y. Lee, Pharm.D., Esq., CPBS, and Adam C. Farkas, Esq. ",
"kicker": "",
"prettyDate": "June 15, 2022",
"timeToRead": "7 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2022/06/AdobeStock_2105272583.jpg",
"width": "750",
"height": "500"
},
"authors": [
{
"webUrl": "/author/profile/jonathan-e-levitt-esq-dae-y-lee-pharmd-esq-cpbs/",
"name": "Jonathan E. Levitt, Esq., Dae Y. Lee, Pharm.D., Esq., CPBS,"
},
{
"webUrl": "/author/profile/adam-c-farkas-esq/",
"name": "Adam C. Farkas, Esq. "
}
],
"kickerNode": [],
"summary": "Far too many pharmacy benefit managers (PBMs) thrive on opacity in their business operations, but sometimes public litigation shines the light of day on secretive practices.",
"body": null
},
{
"uri": "/2021/10/01/how-pbm-rebate-walls-impact-drug-spending-patient-care-and-competition/",
"title": "How PBM \"rebate walls\" impact drug spending, patient care and competition",
"byline": "Jonathan E. Levitt, Esq., Dae Y. Lee, Pharm.D., Esq., CPBS, Jesse C. Dresser, Esq., Andreas Stargard, Esq.",
"kicker": "Commentary",
"prettyDate": "October 01, 2021",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2021/09/AdobeStock_53190533.jpg",
"width": "750",
"height": "498"
},
"authors": [
{
"webUrl": "/author/profile/jonathan-e-levitt-esq-dae-y-lee-pharmd-esq-cpbs-jesse-c-dresser-esq-andreas-stargard-esq/",
"name": "Jonathan E. Levitt, Esq., Dae Y. Lee, Pharm.D., Esq., CPBS, Jesse C. Dresser, Esq., Andreas Stargard, Esq."
}
],
"kickerNode": [
{
"uri": "/commentary/",
"sectionName": "Commentary"
}
],
"summary": "Federal agencies and plan sponsors—the clients of PBMs—are beginning to explore perverse PBM incentives and are waking up to abusive PBM practices.",
"body": null
},
{
"uri": "/2021/04/15/cautionary-tale-plan-sponsors-losing-manufacturer-rebate-dollars-to-pbms-through-rebate-aggregators/",
"title": "Cautionary tale: Plan sponsors losing manufacturer rebate dollars to PBMs through rebate aggregators",
"byline": "Jonathan E. Levitt and Dae Y. Lee",
"kicker": "Expert Opinion",
"prettyDate": "April 15, 2021",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/02/shutterstock_360047027-lawyer-man-gavel-court.jpg",
"width": "700",
"height": "466"
},
"authors": [
{
"webUrl": "/author/profile/jonathan-e-levitt/",
"name": "Jonathan E. Levitt"
},
{
"webUrl": "/author/profile/dae-y-lee/",
"name": "Dae Y. Lee"
}
],
"kickerNode": [
{
"uri": "/expert-opinion/",
"sectionName": "Expert Opinion"
}
],
"summary": "A growing number of examples of PBMs causing economic harm to plan sponsors through rebate aggregators is publicly emerging.",
"body": null
},
{
"uri": "/2020/05/20/plan-sponsor-alert-truths-about-pbm-and-manufacturer-rebates/",
"title": "Plan sponsor alert: truths about PBM and manufacturer rebates",
"byline": "Jonathan E. Levitt, Esq. and Dae Y. Lee, Pharm.D., Esq., CPBS",
"kicker": "Expert Opinion",
"prettyDate": "May 20, 2020",
"timeToRead": "7 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/05/shutterstock_173587901-1.jpg",
"width": "750",
"height": "615"
},
"authors": [
{
"webUrl": "/author/profile/jonathan-e-levitt-esq/",
"name": "Jonathan E. Levitt, Esq."
},
{
"webUrl": "/author/profile/dae-y-lee-pharmd-esq-cpbs/",
"name": "Dae Y. Lee, Pharm.D., Esq., CPBS"
}
],
"kickerNode": [
{
"uri": "/expert-opinion/",
"sectionName": "Expert Opinion"
}
],
"summary": "Plan sponsors should consult with industry experts who have an in-depth knowledge of the PBM industry and who understand PBMs' lingo to uncover self-serving rebate arrangement.",
"body": null
}
]
}
}
